Investigation of The Inhibition of SARS-CoV-2 Spike RBD and ACE-2 Interaction by Phenolics of Propolis Extracts
Abstract
The molecules that consist of propolis are generally polyphenols, and they have many activities such as antiviral, antibacterial and antifungal activities. In this study, it is aimed to investigate the inhibiting capacity of the interaction between ACE-2 and Spike RBS by propolis samples belong to three different cities (Trabzon, Kocaeli, Kırıkkkale). After determining the propolis sample exhibiting the highest inhibition effect, the phenolics within this sample were identified, individual assessments of the inhibition effects of each phenolic compound were conducted with Spike S1 (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit and supported by docking studies in silico. Propolis sample with the highest inhibition effect was determined as 'Kocaeli'. Then, the pure molecules known to be present in Kocaeli propolis were tested and found that p-OH benzoic acid, syringic acid, ferulic acid and gallic acid did not have any inhibitory effects on the Spike S1 (SARS-CoV-2): ACE2 interaction. The substances with the greatest inhibitory effect are; protocathecuic acid, caffeic acid, p-coumaric acid with the inhibition of 62.29%, 58.34%, 59.20%, respectively. The lowest IC50 value of the flavonoids was found to be 0.89 mM with caffeic acid. Over all in silico, in vitro experiments, and MTT analyses conducted in the literature have demonstrated that caffeic acid and protocatechuic acid can be used as a highly active compound against COVID-19.
Keywords
Inhibition, Propolis, Protocathecuic acid, SARS-CoV-2
Supporting Institution
Karadeniz Technical University Scientific Research Projects Coordination Unit of Turkey (KTU-BAP)
Project Number
FBA-2020-9192
Ethical Statement
This study does not require ethics committee permission or any special permission.
References
- Andersen, K.G., Rambaut, A., Lipkin, W.I., Holmes, E.C., & Garry, R.F. (2020). The proximal origin of SARSCoV-2. Nature Medicine, 26(4),450-452.
- Chen, C.T., Chien, Y.H., Yu, Y.H., & Chen, Y.W. (2019). Extraction and Analysis of Taiwanese Green Propolis. JoVE, (143), 58743.
- Cuendet, M., Hostettmann, K., Potterat O., & Dyatmiko, W. (1997). Iridoid Glucosides with Free Radical Scavenging Properties from Fagraea blumei. Helvetica Chimica Acta, 80(4), 1144-1152.
- Cui, J., Li, F., & Shi, Z.L. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3),181‐192.
- Fukumoto, L.R., & Mazza, G. (2000). Assessing antioxidant and prooxidant activities of phenolic compounds. Journal of Agricultural and Food Chemistry, 48(8): 3597-3604.
- Fung, T.S., & Liu, D.X. (2018). Post-translational modifications of coronavirus proteins: roles and function. Future Virology, 13 (6),405-430.
- Güler, H.I, & Kara Y. (2020). Targeting CoV-2 Spike RBD: ACE-II complex with phenolic compounds from Cistus (Cistus L.) Bee Pollen for COVID-19 treatment by molecular docking study. Journal of Apitherapy and Nature, 3(1),10-23.
- Hanwell, M.D., Curtis, E.D., Lonie, D.C., Vandermeersch, T., Zurekand, E., & Hutchison, G.R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4,17.
- Harmer, D., Gilbert, M., Borman, R., & Clark, K.L. (2002). Quantitative mRNA Expression Profiling of ACE 2, a Novel Homologue of Angiotensin Converting Enzyme. FEBS Letters, 532, 107-110.
- Jinag, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., … Zgang, C. (2014). Angiotensin-converting Enzyme 2 and Angiotensin 1-7: Novel Therapeutic Targets. Nature Reviews Cardiology, 11, 413-26. Keskin, M., & Kolaylı, S. (2019). Ticari Propolis Ekstraktlarının Kalite Parametreleri Açısından Karşılaştırılması. Uludag Bee Journal, 19(1).